Farmacias Benavides SAB de CV

Farmacias Benavides SAB de CV

BEVIDESA.MX
Farmacias Benavides SAB de CVMX flagMexican Stock Exchange
- -
MXN
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
24.16
24.57
23.58
24.79
25.98
25.33
28.06
31.19
32.78
33.02
33.79
34.02
33.92
36.06
39.67
42.13
33.56
Revenue per Share
0.2
0.3
0.21
0.51
0.63
0.71
0.25
0.01
-0.26
-1.67
-0.75
-0.33
-0.68
0.17
0.31
0.69
0.01
Basic EPS, GAAP
-0.24
0.85
- -
- -
-0.23
-0.54
0.27
-0.93
-1.35
-3.51
-2.53
0.91
2.02
2.47
2.61
1.61
-1
Free Cash Flow per Basic Share
0.34
0.16
0.33
- -
0.44
0.7
0.32
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
3.03
2.7
2.43
2.94
3.09
3.13
3.06
3.07
2.82
1.15
0.4
0.1
-0.58
-0.41
-0.1
0.59
3.31
Book Value per Share
3.26
3.31
3.04
3.51
3.67
3.66
3.3
3.53
3.09
1.44
0.83
0.46
-0.26
-0.1
0.32
0.91
3.8
Tangible Book Value per Share
412
409
409
409
409
409
409
409
409
409
409
409
409
409
409
409
380
Basic Weighted Avg Shares
9,945
10,046
9,640
10,133
10,622
10,356
11,473
12,752
13,403
13,498
13,814
13,911
13,869
14,743
16,218
17,226
12,752
Sales/Revenue/Turnover
1.8
1.72
0.97
2.91
3.01
3.89
1.25
0.43
-0.17
-3.85
-1.33
1.26
0.81
3.5
4.34
4.97
0.43
Operating Margin (%)
207
236
234
231
223
- -
184
194
185
175
245
523
882
783
1,021
985
194
Depreciation Expense
82
124
87
210
258
290
101
5
-105
-684
-305
-137
-278
70
127
282
5
Net Income, GAAP
25.8
10.69
- -
26.83
24.28
31.86
31.33
90.44
- -
- -
- -
- -
- -
70.26
63.58
35.41
90.44
Effective Tax Rate (%)
0.83
1.24
0.9
2.07
2.43
2.8
0.88
0.04
-0.78
-5.06
-2.21
-0.98
-2.01
0.47
0.78
1.64
0.04
Profit Margin (%)
-499
-299
-300
74
121
27
66
-159
-177
547
163
-1,646
-1,754
-571
-758
-411
-159
Working Capital
62
- -
- -
- -
- -
- -
- -
- -
- -
1,405
1,474
2,220
2,191
2,603
2,623
2,823
- -
LT Debt
1,369
1,373
1,262
1,471
1,531
1,550
1,495
1,516
1,411
726
441
280
-39
19
182
418
1,516
Total Equity
5.87
10.2
- -
15.22
15.74
17.28
6.43
0.35
- -
- -
- -
- -
- -
3.94
7.44
14.55
0.35
Return on Invested Capital (%)
5.88
13.61
- -
20.81
22.21
22.81
7.99
0.49
- -
- -
- -
- -
- -
4.33
8.46
16.3
0.48
Return on Capital (%)
4.16
10.57
8.3
19.11
20.96
22.81
7.99
0.38
-8.69
-84.38
-96.67
-133.8
- -
- -
- -
- -
0.38
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jun'15
Sep'15
Dec'15
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
409
409
409
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Jun'15
Sep'15
Dec'15
Total Current Assets
3,489
3,356
3,469
Cash, Cash Equivalents & STI
521
505
394
Accounts Receivable, Net
214
215
178
Inventories
2,354
2,306
2,454
Total Current Liabilities
3,358
3,240
3,627
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
56.85%
133.06%
130%
Free Cash Flow
-43.89%
-4.93%
-38.12%
Net Income, GAAP
-180.95%
25.36%
121.78%
Sales/Revenue/Turnover
5.3%
4.58%
6.22%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
14,743
2022
- -
- -
- -
- -
16,218
2023
- -
- -
- -
- -
17,226

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
0.17
2022
- -
- -
- -
- -
0.31
2023
- -
- -
- -
- -
0.69

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Business
Farmacias Benavides SAB de CV (BEVIDESB.MX) operates as a leading Mexican pharmacy chain, primarily engaged in the retail of health and wellness products including prescription and over-the-counter medications, personal care and beauty items, non-perishable food and beverages, dermo-cosmetics, baby products, hygiene essentials, photography services, and variety goods such as groceries, confectionery, and cafeteria offerings. The company offers products under its own brands including Almus, No.7, Well Beginnings, and Farmacias Benavides, alongside licensed brands like Boots and Soap & Glory; it provides additional services such as home delivery with free shipping, online pharmacy, medical consultations in affiliated offices, laboratory sample collection, and prescription processing through an extensive network of pharmacies and distribution centers primarily in northern and central Mexico. Founded in 1917 and headquartered in Monterrey, Nuevo Leon, Mexico, at Avenida Fundadores No. 935, Colonia Valle del Mirador, the company serves individual consumers and families focused on health and personal care needs across urban and regional markets. In recent years, Farmacias Benavides has expanded its store footprint to 1,155 locations by the end of 2024, reflecting ongoing operational growth and network optimization amid a competitive drug retail sector. The company, a subsidiary of Walgreens Boots Alliance Inc. via historical acquisitions involving FASA and Farmacias Ahumada, reported positive financial momentum with net profit reaching MXN 189.46 million in the half-year period ending June 2025 and total sales of MXN 4,642.2 million in the latest quarter, supported by strong operating cash flow of MXN 1,540.92 million annually. Key leadership adjustments include a new chief financial officer appointment in early 2025, alongside sustained debt reduction efforts and no major mergers, acquisitions, or funding rounds in the past 1-2 years, emphasizing organic efficiency and market resilience.